↓ Skip to main content

Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
129 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd000525.pub3
Pubmed ID
Authors

Kaushadh Jayakody, Roger Carl Gibson, Ajit Kumar, Shalmini Gunadasa

Abstract

Medication used for acute aggression in psychiatry must have rapid onset of effect, low frequency of administration and low levels of adverse effects. Zuclopenthixol acetate is said to have these properties.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Israel 1 <1%
South Africa 1 <1%
Italy 1 <1%
Canada 1 <1%
Spain 1 <1%
Unknown 122 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 22%
Student > Bachelor 17 13%
Researcher 17 13%
Student > Ph. D. Student 14 11%
Student > Postgraduate 10 8%
Other 26 20%
Unknown 17 13%
Readers by discipline Count As %
Medicine and Dentistry 48 37%
Psychology 20 16%
Nursing and Health Professions 14 11%
Social Sciences 8 6%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Other 11 9%
Unknown 22 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2016.
All research outputs
#6,656,873
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#6,956
of 8,923 outputs
Outputs of similar age
#51,950
of 118,739 outputs
Outputs of similar age from Cochrane database of systematic reviews
#65
of 94 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 118,739 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.